Market Research Report

  The market for oculopharyngeal muscular dystrophy (OPMD) market was estimated to be worth 4.9 billion in 2024, and a compound annual growth rate (CAGR) of 16.1% is anticipated over the course of the projected period. The market is expanding rapidly due to the increased incidence of diabetes and obesity. Consequently, the market is expanding due to muscle illnesses worldwide. It causes vision problems and makes swallowing more challenging. The growing number of glaucoma patients is propelling the market's notable expansion due to the rising incidence of eye conditions and the aging of the world's population. The market is expanding due to advancements in tonometry equipment, the creation of tonometers, and a growing focus on enhancing patient comfort, efficacy, and usability. The creation and distribution of preservative solutions used in ophthalmic drugs and their treatment are the main areas of interest for OPMD. For eye drops and other associated goods to be safe and eff...

  Oculopharyngeal Muscular Dystrophy (OPMD) Market size was estimated at 3.9 billion globally in 2022, and a 14.1% compound annual growth rate (CAGR) is anticipated throughout the forecast period. The growing incidence of diabetes and obesity is propelling the market's expansion. so the market is growing as a result of muscular diseases everywhere in the world. It causes blurred eyesight and makes swallowing food even more difficult. The aging of the world's population and the rising incidence of eye conditions like glaucoma are fueling the market's substantial expansion. The market is expanding due to advancements in tonometry equipment, tonometer development, and a growing focus on enhancing patient comfort, convenience of use, and efficacy. The creation and distribution of preservative solutions for use in ophthalmic drugs and their administration are the main areas of concentration for OPMD. For eye drops and other associated goods to be safe and effective, this mark...